PaulS.BradleyMD
Internal Medicine • Savannah, GASavii Health, Lead Physician; Scripta Insights, Co-founder; Meridian Clinical Research, Principle Investigator
Dr. Bradley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
340 Eisenhower Dr
Suite 1200
Savannah, GA 31406Phone+1 912-443-4200
Education & Training
HCA Healthcare/Mercer University School of Medicine/Memorial Health University Medical CenterResidency, Internal Medicine, 1986 - 1989
Emory University School of MedicineClass of 1986
Certifications & Licensure
GA State Medical License 1987 - 2025- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age Start of enrollment: 2013 Mar 01
- Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults Start of enrollment: 2016 Apr 01
- Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults Start of enrollment: 2022 Feb 22
- Join now to see all
Publications & Presentations
PubMed
- 126 citationsImproved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility.Paul Bradley, Michael Shiekh, Vishaal Mehra, Keith Vrbicky, Stacey Layle
Journal of Psychiatric Research. 2018-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
